Defence Therapeutics Inc.
DTC
CNSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -4.58M | -3.32M | -2.80M | -2.73M | -2.88M |
| Total Depreciation and Amortization | 39.20K | 44.70K | 50.70K | 51.90K | 73.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.67M | 914.30K | 959.10K | 953.60K | 886.90K |
| Change in Net Operating Assets | -398.70K | -1.16M | -1.20M | -669.70K | -270.40K |
| Cash from Operations | -3.27M | -3.51M | -2.99M | -2.40M | -2.19M |
| Capital Expenditure | -11.00K | -11.00K | -15.30K | -- | 12.40K |
| Sale of Property, Plant, and Equipment | -10.80K | -10.80K | 2.50K | 2.50K | 13.30K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -21.80K | -21.80K | -12.80K | 2.50K | 25.70K |
| Total Debt Issued | 2.00M | 2.00M | 2.00M | 15.00K | 65.00K |
| Total Debt Repaid | -18.40K | -40.90K | -170.40K | -183.10K | -187.60K |
| Issuance of Common Stock | 3.62M | 4.24M | 5.02M | 5.02M | 5.03M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -167.60K | -415.00K | -435.80K | -275.70K | -268.80K |
| Cash from Financing | 3.92M | 4.09M | 4.53M | 3.20M | 3.24M |
| Foreign Exchange rate Adjustments | 0.00 | 0.00 | 4.90K | 900.00 | -- |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Net Change in Cash | 634.80K | 550.70K | 1.54M | 799.90K | 1.08M |